Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-10T13:46:14.016Z Has data issue: false hasContentIssue false
  • English
  • Français

Depression in women with metastatic breast cancer: A review of the literature

Published online by Cambridge University Press:  13 November 2008

Aude Caplette-Gingras  and
Josée Savard
Aude Caplette-Gingras
Affiliation:
School of Psychology, Université Laval, Québec, Québec, Canada Laval University Cancer Research Center, Québec, Québec, Canada
Josée Savard*
Affiliation:
School of Psychology, Université Laval, Québec, Québec, Canada Laval University Cancer Research Center, Québec, Québec, Canada
*
Address correspondence and reprint requests to: Josée Savard, Laval University Cancer Research Center, 11 Côte du Palais, Québec, Québec, G1R 2J6, Canada. E-mail: josee.savard@psy.ulaval.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

The aim of this article is to review the available literature on depression in women with metastatic breast cancer in terms of prevalence, potential risk factors, and consequences, as well as pharmacological and psychological interventions.

Method:

An extensive review of the literature was conducted.

Results:

The prevalence of depression appears to be especially elevated in patients with advanced cancer. Many demographic, medical, and psychosocial factors may increase the risk that women will develop depressive symptoms during the course of their illness. Despite the fact that depression appears to be associated with numerous negative consequences, this disorder remains underdiagnosed and undertreated. Both pharmacotherapy and psychotherapy have been found to treat effectively depressive symptoms in this population, but cognitive-behavioral therapy appears to be the most cost-effective approach.

Significance of results:

Areas for future research are suggested.

Keywords

Metastatic breast cancerDepressionCorrelatesPsychotherapyPharmacotherapy
Type
Review Articles
Information
Palliative & Supportive Care , Volume 6 , Issue 4 , December 2008 , pp. 377 - 387
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Aaronson, N.K., Ahmedzai, S., Bergman, B., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.CrossRefGoogle ScholarPubMed
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Association.Google Scholar
Antoni, M.H., Lehman, J.M., Kilbourn, K.M., et al. (2001). Cognitive–behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychology, 20, 20–32.CrossRefGoogle ScholarPubMed
Aragona, M., Muscatello, M.R.A., Losi, E., et al. (1996). Lymphocyte number and stress parameter modifications in untreated breast cancer patients with depressive mood and previous life stress. Journal of Experimental Therapeutics and Oncology, 1, 354–360.Google ScholarPubMed
Arathuzik, D. (1994). Effects of cognitive–behavioral strategies on pain in cancer patients. Cancer Nursing, 17, 207–214.CrossRefGoogle ScholarPubMed
Badger, T.A., Braden, C.J., Mishel, M.H., et al. (2004). Depression burden, psychological adjustment, and quality of life in women with breast cancer: Patterns over time. Research in Nursing and Health, 27, 19–28.CrossRefGoogle ScholarPubMed
Beck, A.T., Rush, A.J., Shaw, B.F., et al. (1979). Cognitive Therapy of Depression. New York: The Guilford Press.Google Scholar
Beck, A.T., Ward, C.E., Mendelson, M., et al. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.CrossRefGoogle ScholarPubMed
Bender, C.M., Ergyn, F.S., Rosenzweig, M.Q., et al. (2005). Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nursing, 28, 219–225.CrossRefGoogle ScholarPubMed
Björkenstam, C., Edberg, A., Ayoubi, S., et al. (2005). Are cancer patients at higher suicide risk than the general population? Scandinavian Journal of Public Health, 33, 208–214.CrossRefGoogle ScholarPubMed
Block, S.D. (2000). Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians—American Society of Internal Medicine. Annals of Internal Medicine, 132, 209–218.CrossRefGoogle ScholarPubMed
Bowers, L. & Boyle, D.A. (2003). Depression in patients with advanced cancer. Clinical Journal of Oncology Nursing, 7, 281–288.CrossRefGoogle ScholarPubMed
Breitbart, W., Rosenfeld, B., Pessin, H., et al. (2000). Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA, 284, 2907–2911.CrossRefGoogle ScholarPubMed
Brown, C., Battista, D.R., Bruehlman, R., et al. (2005). Beliefs about antidepressant medications in primary care patients: Relationship to self-reported adherence. Medical Care, 43, 1203–1207.CrossRefGoogle ScholarPubMed
Butler, L.D., Koopman, C., Cordova, M.J., et al. (2003). Psychological distress and pain significantly increase before death in metastatic breast cancer patients. Psychosomatic Medicine, 65, 416–426.CrossRefGoogle ScholarPubMed
Byar, K.L., Berger, A.M., Bakken, S.L., et al. (2006). Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncology Nursing Forum, 33, E18–26.CrossRefGoogle ScholarPubMed
Carpenter, J.S., Elam, J., Ridner, S., et al. (2004). Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncology Nursing Forum, 31, 591–598.CrossRefGoogle ScholarPubMed
Chambless, D.L. & Ollendick, T.H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685–716.CrossRefGoogle ScholarPubMed
Chochinov, H.M., Wilson, K.G., Enns, M., et al. (1995). Desire for death in the terminally ill. American Journal of Psychiatry, 152, 1185–1191.Google ScholarPubMed
Ciaramella, A. & Poli, P. (2001). Assessment of depression among cancer patients: The role of pain, cancer type and treatment. Psycho-oncology, 10, 156–165.CrossRefGoogle Scholar
Classen, C., Butler, L.D., Koopman, C., et al. (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer. Archives of General Psychiatry, 58, 494–501.CrossRefGoogle ScholarPubMed
Dunkel-Schetter, C., Feinstein, L.G., Taylor, S.E., et al. (1992). Patterns of coping with cancer. Health Psychology, 11, 79–87.CrossRefGoogle ScholarPubMed
Edelman, S., Bell, D.R. & Kidman, A.D. (1999 a). A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psycho-oncology, 8, 295–305.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Edelman, S., Lemon, J., Bell, D.R., et al. (1999 b). Effects of group CBT on the survival time of patients with metastatic breast cancer. Psycho-oncology, 8, 474–481.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Edmonds, C.V.I., Lockwood, G.A. & Cunningham, A.J. (1999). Psychological response to long term group therapy: A randomized trial with metastatic breast cancer patients. Psycho-oncology, 8, 74–91.3.0.CO;2-K>CrossRefGoogle Scholar
Filiberti, A., Ripamonti, C., Totis, A., et al. (2001). Characteristics of terminal cancer patients who committed suicide during a home palliative care program. Journal of Pain and Symptom Management, 22, 544–553.CrossRefGoogle ScholarPubMed
Fisch, M. (2004). Treatment of depression in cancer. Journal of the National Cancer Institute Monographs, 105–111.CrossRefGoogle ScholarPubMed
Fisch, M.J., Loehrer, P.J., Kristeller, J., et al. (2003). Fluoxetine versus placebo in advanced cancer outpatients: A double-blinded trial of the Hoosier Oncology Group. Journal of Clinical Oncology, 21, 1937–1943.CrossRefGoogle ScholarPubMed
Fulton, C. (1998). The prevalence and detection of psychiatric morbidity in patients with metastatic breast cancer. European Journal of Cancer Care, 7, 232–239.CrossRefGoogle ScholarPubMed
Fulton, C.L. (1997). The physical and psychological symptoms experienced by patients with metastatic breast cancer before death. European Journal of Cancer Care, 6, 262–266.CrossRefGoogle ScholarPubMed
Given, C., Given, B., Rahbar, M., et al. (2004). Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. Journal of Clinical Oncology, 22, 507–516.CrossRefGoogle ScholarPubMed
Goodwin, J.S., Zhang, D.D. & Ostir, G.V. (2004). Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. Journal of the American Geriatrics Society, 52, 106–111.CrossRefGoogle ScholarPubMed
Goodwin, P., Leszcz, M., Ennis, M., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine, 345, 1719–1726.CrossRefGoogle ScholarPubMed
Greenberg, D.B. (2004). Barriers to the treatment of depression in cancer patients. Journal of the National Cancer Institute Monographs, 127–135.CrossRefGoogle Scholar
Hamilton, M.A. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–61.CrossRefGoogle ScholarPubMed
Hirai, K., Suzuki, Y., Tsuneto, S., et al. (2002). A structural model of the relationships among self-efficacy, psychological adjustment, and physical condition in Japanese advanced cancer patients. Psycho-oncology, 11, 221–229.CrossRefGoogle ScholarPubMed
Holland, J.C., Romano, S.J., Heiligenstein, J.H., et al. (1998). A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psycho-oncology, 7, 291–300.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Hopwood, P., Howell, A. & Maguire, P. (1991 a). Psychiatric morbidity in patients with advanced cancer of the breast: Prevalence measured by two self-rating questionnaires. British Journal of Cancer, 64, 349–352.CrossRefGoogle ScholarPubMed
Hopwood, P., Howell, A. & Maguire, P. (1991 b). Screening for psychiatric morbidity in patients with advanced breast cancer: Validation of two self-report questionnaires. British Journal of Cancer, 64, 353–356.CrossRefGoogle ScholarPubMed
Hotopf, M., Chidgey, J., Addington-Hall, J., et al. (2002). Depression in advanced disease: A systematic review, Part 1. Prevalence and case finding. Palliative Medicine, 16, 81–97.Google ScholarPubMed
Kathol, R.G., Mutgi, A., Williams, J., et al. (1990). Diagnosis of major depression in cancer patients according to four sets of criteria. American Journal of Psychiatry, 147, 1021–1024.Google ScholarPubMed
Kelly, B., Burnett, P., Pelusi, D., et al. (2003). Factors associated with the wish to hasten death: A study of patients with terminal illness. Psychological Medicine, 33, 75–81.CrossRefGoogle Scholar
Kessler, R.C., McGonagle, K.A., Zhao, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.CrossRefGoogle ScholarPubMed
Kissane, D.W., Clarke, D.M., Ikin, J., et al. (1998). Psychological morbidity and quality of life in Australian women with early-stage breast cancer: A cross-sectional survey. Medical Journal of Australia, 169, 192–196.CrossRefGoogle ScholarPubMed
Kissane, D.W., Grabsch, B., Love, A., et al. (2004). Psychiatric disorder in women with early stage and advanced breast cancer: A comparative analysis. Australian and New Zealand Journal of Psychiatry, 38, 320–326.CrossRefGoogle ScholarPubMed
Koopman, C., Nouriani, B., Erickson, V., et al. (2002). Sleep disturbances in women with metastatic breast cancer. Breast Journal, 8, 362–370.CrossRefGoogle ScholarPubMed
Kugaya, A., Akechi, T., Nakano, T., et al. (1999). Successful antidepressant treatment for five terminally ill cancer patients with major depression, suicidal ideation and a desire for death. Supportive Care in Cancer, 7, 432–436.CrossRefGoogle Scholar
Ladd, C.O., Newport, D.J., Ragan, K.A., et al. (2005). Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Depression and Anxiety, 22, 94–97.CrossRefGoogle ScholarPubMed
Lévesque, M., Savard, J., Simard, S., et al. (2004). Efficacy of cognitive therapy for depression among women with metastatic cancer: A single-case experimental study. Journal of Behavior Therapy and Experimental Psychiatry, 35, 287–305.CrossRefGoogle ScholarPubMed
Lloyd-Williams, M., Dennis, M. & Taylor, F. (2004). A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliative Medicine, 18, 558–563.CrossRefGoogle ScholarPubMed
Love, A.W., Grabsch, B., Clarke, D.M., et al. (2004). Screening for depression in women with metastatic breast cancer: A comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Australian and New Zealand Journal of Psychiatry, 38, 526–531.CrossRefGoogle ScholarPubMed
Marchioro, G., Azzarello, G., Checchin, F., et al. (1996). The impact of a psychological intervention on quality of life in non-metastatic breast cancer. European Journal of Cancer, 32A, 1612–1615.CrossRefGoogle ScholarPubMed
Massie, M.J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Institute Monographs, 57–71.CrossRefGoogle ScholarPubMed
Massie, M.J., Gagnon, P. & Holland, J.C. (1994). Depression and suicide in patients with cancer. Journal of Pain and Symptom Management, 9, 325–340.CrossRefGoogle ScholarPubMed
McNair, D.M., Lorr, M. & Droppleman, L.F. (1971). Edits Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.Google Scholar
Meyer, H.A., Sinnott, C. & Seed, P.T. (2003). Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional. Palliative Medicine, 17, 604–607.CrossRefGoogle ScholarPubMed
Miranda, C.R., de Resende, C.N., Melo, C.F., et al. (2002). Depression before and after uterine cervix and breast cancer neoadjuvant chemotherapy. International Journal of Gynecological Cancer, 12, 773–776.CrossRefGoogle ScholarPubMed
Morrow, G.R., Hickok, J.T., Roscoe, J.A., et al. (2003). Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology program. Journal of Clinical Oncology, 21, 4635–4641.CrossRefGoogle ScholarPubMed
Musselman, D.L., Lawson, D.H., Gumnick, J.F., et al. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine, 344, 961–966.CrossRefGoogle ScholarPubMed
Mystakidou, K., Rosenfeld, B., Parpa, E., et al. (2005 a). Desire for death near the end of life: The role of depression, anxiety and pain. General Hospital Psychiatry, 27, 258–262.CrossRefGoogle ScholarPubMed
Mystakidou, K., Tsilika, E., Parpa, E., et al. (2005 b). Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Quality of Life Research, 14, 1825–1833.CrossRefGoogle ScholarPubMed
O'Brien, A.R. (2003). The impact of physical activity on quality of life, depression, and anxiety in breast cancer patients undergoing treatment. Dissertation Abstracts International, 65(5-B), 2397.Google Scholar
Okamura, M., Yamawaki, S., Akechi, T., et al. (2005). Psychiatric disorders following first breast cancer recurrence: Prevalence, associated factors and relationship to quality of life. Japanese Journal of Clinical Oncology, 35, 302–309.CrossRefGoogle ScholarPubMed
O'Mahony, S., Goulet, J., Kornblith, A., et al. (2005). Desire for hastened death, cancer pain and depression: Report of a longitudinal observational study. Journal of Pain and Symptom Management, 29, 446–457.CrossRefGoogle ScholarPubMed
Palesh, O.G., Collie, K., Batiuchok, D., et al. (2007). A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biological Psychology, 75, 37–44.CrossRefGoogle ScholarPubMed
Parker, P.A., Baile, W.F., de Moor, C., et al. (2003). Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psycho-oncology, 12, 183–193.CrossRefGoogle Scholar
Pasacreta, J.V. (1997). Depressive phenomena, physical symptom distress, and functional status among women with breast cancer. Nursing Research, 46, 214–221.CrossRefGoogle ScholarPubMed
Pettingale, K.W., Burgess, C. & Greer, S. (1988). Psychological response to cancer diagnosis—I. Correlations with prognostic variables. Journal of Psychosomatic Research, 32, 255–261.CrossRefGoogle ScholarPubMed
Pinder, K.L., Ramirez, A.J., Black, M.E., et al. (1993). Psychiatric disorder in patients with advanced breast cancer: Prevalence and associated factors. European Journal of Cancer, 29A, 524–527.Google ScholarPubMed
Plumb, M. & Holland, J. (1981). Comparative studies of psychological function in patients with advanced cancer II. Interviewer-rated current and past psychological symptoms. Psychosomatic Medicine, 43, 243–254.CrossRefGoogle ScholarPubMed
Potash, M. & Breitbart, W. (2002). Affective disorders in advanced cancer. Hematology/Oncology Clinics of North America, 16, 671–700.CrossRefGoogle ScholarPubMed
Ranchor, A.V., Sanderman, R., Steptoe, A., et al. (2002). Pre-morbid predictors of psychological adjustment to cancer. Quality of Life Research, 11, 101–113.CrossRefGoogle ScholarPubMed
Razavi, D., Allilaire, J.F., Smith, M., et al. (1996). The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatrica Scandinavica, 94, 205–210.CrossRefGoogle ScholarPubMed
Reiche, E.M., Nunes, S.O. & Morimoto, H.K. (2004). Stress, depression, the immune system, and cancer. Lancet Oncology, 5, 617–625.CrossRefGoogle ScholarPubMed
Reuter, K., Classen, C.C., Roscoe, J.A., et al. (2006). Association of coping style, pain, age and depression with fatigue in women with primary breast cancer. Psycho-oncology, 15, 772–779.CrossRefGoogle ScholarPubMed
Roscoe, J.A., Morrow, G.R., Hickok, J.T., et al. (2005). Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Research and Treatment, 89, 243–249.CrossRefGoogle ScholarPubMed
Rustøen, T., Moum, T., Padilla, G., et al. (2005). Predictors of quality of life in oncology outpatients with pain from bone metastasis. Journal of Pain and Symptom Management, 30, 234–242.CrossRefGoogle ScholarPubMed
Sachs, G., Rasoul-Rockenschaub, S., Aschauer, H., et al. (1995). Lytic effector cell activity and major depressive disorder in patients with breast cancer: A prospective study. Journal of Neuroimmunology, 59, 83–89.CrossRefGoogle ScholarPubMed
Savard, J., Simard, S., Giguere, I., et al. (2006). Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: Psychological and immunological effects. Palliative & Supportive Care, 4, 219–237.CrossRefGoogle ScholarPubMed
Schnoll, R.A., Harlow, L.L., Stolbach, L.L., et al. (1998). A structural model of the relationships among stage of disease, age, coping, and psychological adjustment in women with breast cancer. Psycho-oncology, 7, 69–77.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
Shapiro, S.L., Lopez, A.M., Schwartz, G.E., et al. (2001). Quality of life and breast cancer: Relationship to psychosocial variables. Journal of Clinical Psychology, 57, 501–519.CrossRefGoogle ScholarPubMed
Sharpe, M., Strong, V., Allen, K., et al. (2004). Major depression in outpatients attending a regional cancer centre: Screening and unmet treatment needs. British Journal of Cancer, 90, 314–320.CrossRefGoogle ScholarPubMed
Skarstein, J., Aass, N., Fossa, S.D., et al. (2000). Anxiety and depression in cancer patients: Relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. Journal of Psychosomatic Research, 49, 27–34.CrossRefGoogle ScholarPubMed
Smith, E.M., Gomm, S.A. & Dickens, C.M. (2003). Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliative Medicine, 17, 509–513.CrossRefGoogle ScholarPubMed
Spiegel, D. (1993). Psychosocial intervention in cancer. Journal of the National Cancer Institute, 85, 1198–1205.CrossRefGoogle ScholarPubMed
Spiegel, D., Bloom, J.R. & Yalom, I. (1981). Group support for patients with metastatic cancer: A randomized prospective outcome study. Archives of General Psychiatry, 38, 527–533.CrossRefGoogle Scholar
Spiegel, D. & Giese-Davis, J. (2003). Depression and cancer: Mechanisms and disease progression. Biological Psychiatry, 54, 269–282.CrossRefGoogle ScholarPubMed
Spitzer, R.L., Williams, J.B.W., Gibbon, M. & First, M.B. (1990). Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Press.Google Scholar
Stommel, M., Kurtz, M.E., Kurtz, J.C., et al. (2004). A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychology, 23, 564–573.CrossRefGoogle ScholarPubMed
Suarez-Almazor, M.E., Newman, C., Hanson, J., et al. (2002). Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: Predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival. Journal of Clinical Oncology, 20, 2134–2141.CrossRefGoogle ScholarPubMed
Van der Lee, M.L., van der Bom, J.G., Swarte, N.B., et al. (2005). Euthanasia and depression: A prospective cohort study among terminally ill cancer patients. Journal of Clinical Oncology, 23, 6607–6612.CrossRefGoogle ScholarPubMed
Van Heeringen, K. & Zivkov, M. (1996). Pharmacological treatment of depression in cancer patients: A placebo-controlled study of Mianserin. British Journal of Psychiatry, 169, 440–443.CrossRefGoogle ScholarPubMed
Watson, M., Feldman-Stewart, M.D., Brundage, C., et al. (2005). A conceptual framework for patient-professional communication: An application to the cancer context. Psycho-oncology, 14, 801–809.Google Scholar
Watson, M., Haviland, J.S., Greer, S., et al. (1999). Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet, 354, 1331–1336.CrossRefGoogle ScholarPubMed
Weitzner, M.A., Meyers, C.A., Stuebing, K.K., et al. (1997). Relationship between quality of life and mood in long-term survivors of breast cancer treated with mastectomy. Supportive Care in Cancer, 5, 241–248.CrossRefGoogle ScholarPubMed
Weitzner, M.A., Moncello, J., Jacobsen, P.B., et al. (2002). A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. Journal of Pain and Symptom Management, 23, 337–345.CrossRefGoogle ScholarPubMed
Werth, J.L. Jr., Gordon, J.R. & Johnson, R.R. Jr. (2002). Psychosocial issues near the end of life. Aging & Mental Health, 6, 402–412.Google ScholarPubMed
Williams, S. & Dale, J. (2006). The effectiveness of treatment for depression/depressive symptoms in adults with cancer: A systematic review. British Journal of Cancer, 94, 372–390.CrossRefGoogle ScholarPubMed
Winzelberg, A.J., Classen, C., Alpers, G.W., et al. (2003). Evaluation of an internet support group for women with primary breast cancer. Cancer, 97, 1164–1173.CrossRefGoogle ScholarPubMed
Wong-Kim, E.C. & Bloom, J.R. (2005). Depression experienced by young women newly diagnosed with breast cancer. Psycho-oncology, 14, 564–573.CrossRefGoogle ScholarPubMed
Zigmond, A.S. & Snaith, R.P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361–370.CrossRefGoogle ScholarPubMed